Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07237295 · ClinicalTrials.gov registry record · NA
CommunityRx-Kidney Health
A NA study of Chronic Kidney Disease (Stages 1-4), sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 634
- Enrollment target
- 1
- Study location
NCT07237295 is a NA study of Chronic Kidney Disease (Stages 1-4) that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 634 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07237295, a NA study of Chronic Kidney Disease (Stages 1-4), is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 634 participants
- Enrollment target
- 1
- Study location
Study Summary
In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care resources to improve CKD management in rural eastern North Carolina. Through a partnership among local primary care centers, community organizations, and researchers, CRx-K will strengthen rural care networks, improve CKD management, and enhance the well-being of rural communities.
Conditions Studied
Interventions
- BEHAVIORAL CommunityRx-Kidney Health
Study Locations (1)
North Carolina
- Goshen Medical Center - Beulaville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 634 participants |
| Start Date | 2026-03 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07237295
The ClinicalTrials.gov registry entry for NCT07237295 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 634 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Kidney Disease (Stages 1-4) appearing as the primary indexed condition, and to 1 intervention - of which CommunityRx-Kidney Health is the first listed.
NCT07237295 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07237295 about?
NCT07237295 is a clinical study titled "CommunityRx-Kidney Health". In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care re...
What is the current status of trial NCT07237295?
This trial is currently recruiting. It is a NA study. The enrollment target is 634 participants. The study started on 2026-03. Estimated completion is 2027-12.
What conditions does trial NCT07237295 study?
This clinical trial studies the following conditions: Chronic Kidney Disease (Stages 1-4).
What interventions are being tested in trial NCT07237295?
The interventions under investigation include: CommunityRx-Kidney Health (BEHAVIORAL).
Who is sponsoring clinical trial NCT07237295?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07237295 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.